FDA Inspection 1081447 — Midas-Care Pharmaceuticals Pvt. Ltd.

Midas-Care Pharmaceuticals Pvt. Ltd. — FEI 3007542588

The FDA completed an inspection of Midas-Care Pharmaceuticals Pvt. Ltd. on Jan 31, 2019 in Aurangabad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 31, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Aurangabad (India)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance